Eleni Lagkadinou

New Capabilities

Leading early development of Temab-A

The FDA granted AbbVie's experimental cancer drug Temab-A two breakthrough therapy designations on October 7. One covers colorectal cancer, the other non-small cell lung cancer. The designations speed up development and review for drugs that show early evidence of substantial improvement over existing therapies.

Updated 2 hours ago